ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 207.00
+0.80 (0.39%)
Sep 16, 2025, 4:30 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 45.79 billion as of September 16, 2025. Its market cap has increased by 16.29% in one year.
Market Cap
45.79B
Enterprise Value
45.87B
Revenue
5.86B
Ranking
n/a
PE Ratio
46.29
Stock Price
207.00
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 45.79B, an increase of 562.80%. That is a compound annual growth rate of 10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 45.79B | 30.11% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | 27.29B | 53.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,577.86B |
| Coloplast | 137.35B |
| Genmab | 109.51B |
| Demant | 50.91B |
| H. Lundbeck | 40.58B |
| Zealand Pharma | 30.18B |
| Ambu A/S | 25.93B |
| Bavarian Nordic | 18.14B |